Suchergebnisse - "Letter"

PubPharm (3.415)

1

Secretory carcinoma in the parotid gland presenting as a cystic lesion and harboring ETV6‑NTRK3 gene rearrangement

enthalten in: Oral oncology | 2024

von Leng, X. | Sun, X. | Lin, Y. | +3

2

A case of HER-2 positive breast metaplastic carcinoma : The medium-highly differentiated squamous cell carcinoma

enthalten in: Asian journal of surgery | 2024

von Li, Y. | Song, G. | Su, H. | +1

3

Reply to comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al

enthalten in: Breast cancer (Tokyo, Japan) | 2024

von Fukui, R. | Watanabe, T. | Morimoto, K. | +5

4

Peritoneal effusion : an uncommon adverse effect of selective RET inhibitors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Belli, C. | Curigliano, G.

5

A link between KIT expression, mast cell abundance and activity, and Th2-high endotype in asthmatic airways

enthalten in: Allergy | 2024

von Tran, N. | Le, M. | Nakamura, Y. | +2

6

The association of ROS1 mutation with cancer immunity and its impact on the efficacy of pan-cancer immunotherapy

enthalten in: Journal of translational medicine | 2024

von Li, Y. | Zhao, H. | Huang, J. | +2

7

Real-world experiences with intravitreal treatment with ranibizumab and aflibercept for diabetic macular oedema 2008-2021

enthalten in: Acta ophthalmologica | 2024

von Lindboe, J. | Brynskov, T. | Sørensen, T. | +1

8

Adolescent presentation of FGFR1::EBF2 gene fusion mesenchymal tumor

enthalten in: Genes, chromosomes & cancer | 2024

von Jaber, O. | Sultan, I.

9

Two novel tumours with NTRK2 fusion in the methylation class of extraventricular neurocytomas, including one intraventricular

enthalten in: Brain pathology (Zurich, Switzerland) | 2024

von Uro-Coste, E. | Tauziede-Espariat, A. | Dubucs, C. | +12

10

Cutaneous adverse events following treatment with third-generation EGFR tyrosine kinase inhibitors

enthalten in: Italian journal of dermatology and venereology | 2024

von Li Pomi, F. | Vaccaro, F. | Borgia, F. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[342]